| |
|
|
|
ADMA Biologics Inc.  
|
|
4.04 -0.03 (-0.01%) |
07-15 16:00 |
|
Open: |
4.07 |
Pre close: |
4.07 |
Target:
|
4.81 
|
|
High: |
4.12 |
Low: |
3.985 |
Resistance:
|
4.12
4.81
|
|
Volume: |
511,250 |
Market Cap: |
240M |
Support:
|
3.71
3.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.01
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
3.79 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
4.22 |
Stochastic Oscillator |
%K(14,3):
|
82.10  |
|
MA(250): |
4.65 |
%D(3): |
81.72 |
|
Average Volume(K) |
3-Month: |
97277
|
52-Week |
High:
|
6.96 |
|
10-Days: |
79767 |
Low: |
2.08 |
|
RSI |
RSI(14):
|
54.15 |
Change(%): |
-12.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.342 |
Return on Equity (ttm) |
-368.9 |
Shares Out. (M) |
46.38 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-42.1 |
Shares Float (M) |
21.27 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
25.50 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
-12.7 |
% Held by Institutions |
57.51 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
-0.544 |
Shares Short (K) |
3990 |
|
Book Value (p.s.) |
0.220 |
EBITDA (p.s.) |
-1.167 |
P/E |
-3.01 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
18.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-60.53 |
P/S |
520486688.00 |
|
Operating Margin |
-345.83 |
Levered Free Cash Flow
(M) |
-37.40 |
P/CF |
-3.10 |
|
|
|
|
|
|
